Is pharma its own worst enemy?

Make sure your worst enemy is not living between your own two earsOne of the questions I get asked and asked again is “why haven’t most pharma companies changes in their approach to DTC and digital marketing?”.  The answer to this is complex, but at its heart most major consulting research has indicated that time and time again pharma is a laggard when it comes to change and hiring people who can really question current thinking when it comes to meeting the needs of consumers of healthcare. Continue reading »

How to measure the ROI of medical meetings

medical meetingPOST SUMMARY: Sponsoring a medical meeting can be expensive in dollars and time and there are ways to measure the ROI of these meetings.  The key is to understand the most important metric, for ROI, for your organization and then generate buy-in from key stakeholders. Continue reading »

Sanofi Fires CEO: Key lessons

UnknownPOST SUMMARY: The chief executive of Sanofi, Christopher Viehbacher, was fired this week by the French drug maker, but although his performance as CEO was admirable the key reason for his ouster was both a failure to communicate and a clash of cultures. Continue reading »

Pharma CEO’s: R&D versus pleasing shareholders

pharmaceutical r&DPOST SUMMARY: When it comes to investing in R&D “Wall Street cares about the business model. We care less about changing the world,” said Laura Martin, an analyst with Needham & Company. Can the drug find the courage to invest more in R&D when it’s more about the balance sheet? Continue reading »

Emerging mHealth

screenshot_59Mobile healthcare (mHealth) is “the biggest technology breakthrough of our time [being used] to address our greatest national challenge”, said US Health and Human Services Secretary, Kathleen Sebelius in her keynote address at the 2011 annual mHealth Summit in the Washington, DC area. Worldwide, the technology and its promise have moved up the healthcare agenda

Doctors are not technologists

102011code2In the past, when we bought new software, you would receive thick instruction books included with your purchase.  There was just one problem, users rarely read the manuals and only referred to them when they had questions.  So why would any company think that over 200 pages in update notes would be read by physicians and office staff who are time stressed? Continue reading »

Content and innovation for pharma marketers

Bright IdeaPOST SUMMARY: If you want to excel as an innovator in the future, don’t set out to copy and improve what someone else has already done. Focus on your audience and deliver a great online brand experience while answering their concerns about living with health conditions. Continue reading »